NCT00001165View on ClinicalTrials.gov

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

PHASE2CompletedINTERVENTIONAL
Enrollment

999

Participants

Timeline

Start Date

September 30, 1978

Study Completion Date

August 31, 2003

Conditions
Islet Cell AdenomaNeoplasm MetastasisZollinger Ellison Syndrome
Interventions
DRUG

combined chemotherapy with streptozotocin, 5-fluorouracil, and doxorubicin

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00001165 - Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas | Biotech Hunter | Biotech Hunter